Memantine benefits functional abilities in moderate to severe Alzheimer’s disease

被引：0

作者：

Bengt Winblad

S. Gauthier

D. Åström

K. Stender

机构：

[1] Alzheimer Disease Research Center (KI-ADRC) NOVUM,Karolinska Institutet

[2] Douglas Institute for Mental Health,McGill Center for Studies in Aging

[3] H. Lundbeck A/S,Karolinska Institutet

[4] Alzheimer Disease Research Center (KI-ADRC) NOVUM,undefined

来源：

The journal of nutrition, health & aging | 2010年 / 14卷

关键词：

Memantine; Alzheimer’s disease; functional ability;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：770 / 774

页数：4

共 50 条

[41] Effects of Memantine on Language and Functional Communication in Patients with Moderate to Severe Alzheimer's Disease: A Pooled Analysis
Saxton, Judith
Tocco, Michael
Hofbauer, Robert K.
Graham, Stephen M.
NEUROLOGY, 2009, 72 (11) : A298 - A298
[42] Effects of Memantine on Language and Functional Communication in Patients with Moderate to Severe Alzheimer's Disease: a Pooled Analysis
Saxton, J.
Tocco, M.
Hofbauer, R. K.
Graham, S. M.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 : S170 - S170
[43] Spotlight on Memantine in Moderate to Severe Alzheimer’s Diseasey
Kate McKeage
Drugs & Aging, 2010, 27 : 177 - 179
[44] Memantine has positive effects on behaviour in moderate to severe Alzheimer's disease
Gauthier, S.
Wirth, Y.
Stoeffler, A.
Moebius, H. J.
EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 188 - 188
[45] Added Therapeutic Value of Memantine in the Treatment of Moderate to Severe Alzheimer’s Disease
T. Heinen-Kammerer
H. Rulhoff
S. Nelles
R. Rychlik
Clinical Drug Investigation, 2006, 26 : 303 - 314
[46] Added therapeutic value of memantine in the treatment of moderate to severe Alzheimer's disease
Heinen-Kammerer, T.
Rulhoff, H.
Nelles, S.
Rychlik, R.
CLINICAL DRUG INVESTIGATION, 2006, 26 (06) : 303 - 314
[47] Memantine and individual activities of daily living in moderate to severe Alzheimer's disease
Feldman, H
Schmitt, FA
Doraiswamy, PM
Graham, SM
Bell, JM
NEUROLOGY, 2005, 64 (06) : A103 - A104
[48] Positive effects of memantine treatment in patients with moderate to severe Alzheimer's disease
Gauthier, S
Wirth, Y
Moebius, HJ
INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 206 - 206
[49] Memantine and individual activities of daily living in moderate to severe Alzheimer's disease
Feldman, H
Schmitt, E
Pfeiffer, E
Graham, SM
Bell, JM
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S570 - S570
[50] Cost-effectiveness of memantine in moderate and severe Alzheimer's disease in Norway
Rive, B.
Aarsland, D.
Grishchenko, M.
Cochran, J.
Lamure, M.
Toumi, M.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2012, 27 (06) : 573 - 582

← 1 2 3 4 5 →